Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Singapore
  4. Singapore Stock Exchange
  5. TalkMed Group Limited
  6. Summary
    5G3   SG2G61000003

TALKMED GROUP LIMITED

(5G3)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Singapore Stock Exchange
05/24/2021 05/27/2021 06/01/2021 06/04/2021 06/11/2021 Date
0.4 0.42 0.4 0.405 0.41 Last
25000 113400 218600 50000 10000 Volume
0.00% +5.00% -4.76% +1.25% +1.23% Change
Financials
Sales 2021 59,9 M 45,2 M 45,2 M
Net income 2021 24,9 M 18,8 M 18,8 M
Net Debt 2021 - - -
P/E ratio 2021 20,5x
Yield 2021 2,44%
Sales 2022 61,6 M 46,5 M 46,5 M
Net income 2022 25,6 M 19,3 M 19,3 M
Net Debt 2022 - - -
P/E ratio 2022 20,5x
Yield 2022 2,44%
Capitalization 541 M 408 M 408 M
Capi. / Sales 2021 9,04x
Capi. / Sales 2022 8,79x
Nbr of Employees -
Free-Float 16,4%
More Financials
Company
TalkMed Group Limited is a Singapore-based investment holding company. The Company's principal activities are the provision of medical oncology services and stem cell transplant services. The Company's segments include Oncology services and Stem cells services. Its doctors provide tertiary healthcare services in the fields of medical oncology, stem cell transplant and palliative care to the oncology patients in the... 
More about the company
Ratings of TalkMed Group Limited
Trading Rating :  -
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about TALKMED GROUP LIMITED
05/11GENERAL ANNOUNCEMENT : :Minutes of Annual General Meeting held on 20 April 2021
PU
05/04Singapore Shares Slip on Tuesday; AEM Shares Fall over 6% on Lower First Quar..
MT
05/04TALKMEDá : Singapore's TalkMed Gets License to Operate Medical Center in Beijing
MT
04/12TALKMEDá : Oncology Hospital JV in China Obtains Practice License
MT
04/04ANNUAL REPORTS AND RELATED DOCUMENTS : :
PU
03/15TALKMEDá : Issues Nearly 2 Million New Shares Under Employee Incentive Plan
MT
02/19TALKMEDá : Posts Lower Profit for Forth Quarter 2020
MT
2020TALKMEDá : Declares Dividend Despite 41% Decline in Q3 Profit
MT
2020FINANCIAL STATEMENTS AND RELATED ANN : Third Quarter Results
PU
2020GENERAL ANNOUNCEMENT : Minutes of Annual General Meeting (note: this announcemen..
PU
2020CASH DIVIDEND/ DISTRIBUTION : :Mandatory
PU
2019CHANGE - CHANGE IN CORPORATE INFORMA : :incorporation of subsidiary and restruct..
PU
More news
News in other languages on TALKMED GROUP LIMITED

- No features available -

More news
Chart TALKMED GROUP LIMITED
Duration : Period :
TalkMed Group Limited Technical Analysis Chart | 5G3 | SG2G61000003 | MarketScreener
Technical analysis trends TALKMED GROUP LIMITED
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 1
Average target price 0,49 SGD
Last Close Price 0,41 SGD
Spread / Highest target 19,5%
Spread / Average Target 19,5%
Spread / Lowest Target 19,5%
EPS Revisions
Managers and Directors
NameTitle
Peng Tiam Ang Chief Executive Officer & Executive Director
Boon Yong Lee Chief Financial Officer & Joint Secretary
Sitaram Chandra Das Independent Non-Executive Chairman
Kei Siong Khoo Chief Operating Officer & Executive Director
Yih Pin Sitoh Independent Non-Executive Director
Sector and Competitors